Zdrowie i gospodarka · 08/03/2000
FDA Withdraws Proposed Rule on Patent Holder Notification for New Drugs
The Food and Drug Administration (FDA) has withdrawn its proposed rule regarding the certification of invalidity or noninfringement of patents for new drugs, following comments from large corporations that expressed difficulties in tracking delivery receipts.